Cancer cells experience higher oxidative stress from reactive oxygen species (ROS) than do non-malignant cells because of genetic alterations and abnormal growth; as a result, maintenance of the antioxidant glutathione (GSH) is essential for their survival and proliferation1, 2, 3. Under conditions of elevated ROS, endogenous L-cysteine (L-Cys) production is insufficient for GSH synthesis. This necessitates uptake of L-Cys that is predominantly in its disulfide form, L-cystine (CSSC), via the xCT(−) transporter. We show that administration of an engineered and pharmacologically optimized human cyst(e)inase enzyme mediates sustained depletion of the extracellular L-Cys and CSSC pool in mice and non-human primates. Treatment with this enzyme selectively causes cell cycle arrest and death in cancer cells due to depletion of intracellular GSH and ensuing elevated ROS; yet this treatment results in no apparent toxicities in mice even after months of continuous treatment. Cyst(e)inase suppressed the growth of prostate carcinoma allografts, reduced tumor growth in both prostate and breast cancer xenografts and doubled the median survival time of TCL1-Tg:p53−/− mice, which develop disease resembling human chronic lymphocytic leukemia. It was observed that enzyme-mediated depletion of the serum L-Cys and CSSC pool suppresses the growth of multiple tumors, yet is very well tolerated for prolonged periods, suggesting that cyst(e)inase represents a safe and effective therapeutic modality for inactivating antioxidant cellular responses in a wide range of malignancies4, 5.
At a glance
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579–591 (2009). , &
- The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17 (2014). &
- Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211–222 (2015). et al.
- [Effect of phenethyl isothiocyanate given at different duration of gestation on the outcome of pregnancy in rats]. J. Hyg. Res. 40, 283–286 (2011). , , , &
- Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. Carcinogenesis 27, 240–244 (2006). &
- IV. Transsulfuration is a significant source of sulfur for glutathione production in human mammary epithelial cells. ISRN Biochem. 2013, 637897 (2013). , , , &
- The distribution of cystathionine β-synthase (CBS) in the eye: implication of the presence of a trans-sulfuration pathway for oxidative stress defense. Exp. Eye Res. 83, 817–823 (2006). , , , &
- A functional transsulfuration pathway in the brain links to glutathione homeostasis. J. Biol. Chem. 281, 35785–35793 (2006). , , , &
- Expression of cystathionine β-synthase and cystathionine γ-lyase in human pregnant myometrium and their roles in the control of uterine contractility. PLoS One 6, e23788 (2011). et al.
- Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. PLoS One 7, e49683 (2012). et al.
- Expression of cystathionine β-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol. Rep. 21, 1449–1454 (2009). et al.
- Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24, 853–863 (2013). et al.
- Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery 72, 33–41 discussion 41, (2013). et al.
- xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma. J. Gastroenterol. bok49, 1–11 (2014). et al.
- Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate 67, 162–171 (2007). et al.
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat. Cell Biol. 14, 276–286 (2012). et al.
- De novo engineering of a human cystathionine-γ-lyase for systemic L-methionine depletion cancer therapy. ACS Chem. Biol. 7, 1822–1829 (2012). et al.
- Site-directed mutagenesis on human cystathionine-γ-lyase reveals insights into the modulation of H2S production. J. Mol. Biol. 396, 708–718 (2010). et al.
- Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 68, 1777–1785 (2008). , , , &
- Reactive oxygen species signaling in cancer: comparison with aging. Aging Dis. 2, 219–230 (2011).
- ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells. Mol. Carcinog. 55, 27–39 (2016). et al.
- Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo. Oncotarget 7, 25194–25207 (2016). , , , &
- Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223–238 (2003). et al.
- Redox implications of AMPK-mediated signal transduction beyond energetic clues. J. Cell Sci. 125, 2115–2125 (2012). , &
- Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-β (CaMKK-β). J. Biol. Chem. 287, 38625–38636 (2012). , , &
- Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol. Cell. Biol. 31, 3531–3545 (2011). et al.
- The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 9, 218–224 (2007). et al.
- AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283–293 (2005). et al.
- Foye's Principles of Medicinal Chemistry, 2007 (Lippincott Williams & Wilkins, 2007). , &
- The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J. Exp. Biol. 208, 1575–1592 (2005). &
- The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid. Redox Signal. 18, 522–555 (2013). et al.
- Cystine/glutamate antiporter expression in retinal Müller glial cells: implications for DL-alpha-aminoadipate toxicity. Neuroscience 57, 473–482 (1993). , , &
- Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res. 23, 4571–4579 (2003). , , , &
- Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J. Biol. Chem. 280, 25284–25290 (2005). , &
- A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother. Pharmacol. 71, 1521–1530 (2013). et al.
- Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. (Phila.) 4, 354–364 (2011). et al.
- A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 68, 157–164 (2011). et al.
- Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(−/−) mouse model and primary human leukemia cells. Leukemia 28, 118–128 (2014). et al.
- The yin and yang of redox regulation. Redox Rep. 18, 245–252 (2013). , &
- p53 and metabolism. Nat. Rev. Cancer 9, 691–700 (2009). &
- Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res. 65, 1554–1560 (2005). et al.
- System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J. Biol. Chem. 285, 22244–22253 (2010). et al.
- Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase. Proc. Natl. Acad. Sci. USA 111, 6964–6969 (2014). et al.
- Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 112, 1912–1922 (2008). et al.
- Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Mol. Med. Rep. 12, 7374–7388 (2015). et al.
- Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species–mediated endoplasmic reticulum stress. Sci. Rep. 5, 10420 (2015). et al.
- Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J. Pharmacol. Exp. Ther. 335, 114–123 (2010). , , , &
- Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance. Free Radic. Biol. Med. 52, 452–461 (2012). , , , &
- Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997). &
- Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007). et al.
- Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010). , , &
- The PyMOL molecular graphics system (Schrödinger LLC, 2002).
- Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am. J. Hematol. 29, 152–163 (1988). et al.
- Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine. Leukemia 14, 1405–1413 (2000). , , , &
- Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem. 278, 37832–37839 (2003). et al.
- Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal. Biochem. 377, 16–23 (2008). et al.
- KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 36, W423–W426 (2008). et al.
- HMDB: the human metabolome database. Nucleic Acids Res. 35, D521–D526 (2007). et al.
- Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC/TOF-MS. J Biomol Tech 19, 258–266 (2008). , , , &
- Supplementary Figures, Table & Text (3,724 KB)
Supplementary Figures 1–14, Supplementary Table 1, Supplementary Methods and Dataset